Sort
326,823 grants matching “clinical trial”
Molecular Diagnostics Core Laboratory
$1,793,683Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
HPV Vaccine Trial
$1,793,621Aimee Kreimer · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
Molecular and Clinical Manifestations of Matrix and Aggregate Myopathies
$1,793,609Carsten Bonnemann · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Spastic Paraplegia Centers of Excellence Research Network (SP-CERN) - RDCRC
$1,793,539Darius Ebrahimi-Fakhari · Boston Children'S Hospital · U54 · FY2025 · NS
ADMINISTRATIVE CORE
$1,793,520Paul S. Aisen · University Of California, San Diego · U19 · FY2014 · AG
CHEMOPREVENTION FOR WOMEN AT HIGH RISK OF BREAST CANCER
$1,793,476University Of Kansas Medical Center · U01 · FY2002 · CA
SOUTHEAST CANCER CONTROL COSORTIUM, INC
$1,793,458Southeast Cancer Control Consortium · U10 · FY2002 · CA
A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials
$1,793,408Kathleen N. Moore · University Of Oklahoma Hlth Sciences Ctr · UG1 · FY2021 · CA
Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease
$1,793,405William T Dauer · University Of Michigan At Ann Arbor · P50 · FY2017 · NS
SPORE in Prostate Cancer
$1,793,395William George Nelson · Johns Hopkins University · P50 · FY2015 · CA
Statistical and Data Coordinating Center: SARS-CoV-2/COVID-19 Vaccine Studies
$1,793,371Marian Ewell · The Emmes Company, Llc · N01 · FY2023 · AI
Hyperandrogenemia, Diet and Female Reproductive Health
$1,793,187Richard L Stouffer · Oregon Health & Science University · P50 · FY2014 · HD
Ontario Registry for Studies of Familial Colon Cancer
$1,793,154Cancer Care Ontario · U01 · FY2003 · CA
Multi-Center Uveitis Steriod Treatment (MUST) Trial
$1,793,111Johns Hopkins University · U10 · FY2005 · EY
Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study
$1,793,103Catherine A Spino · University Of Michigan At Ann Arbor · U24 · FY2022 · HL
STEM CELL THERAPY OF CONGENITAL DEFECTS IN HEMATOPOIESIS
$1,793,037Dana-Farber Cancer Institute · P50 · FY2003 · HL
1/2 PROSpect: Prone and Oscillation Pediatric Clinical Trial (CCC)
$1,792,742Martha Aq Curley · University Of Pennsylvania · UH3 · FY2019 · HL
A randomized, double blind, placebo-controlled study to evaluate the impact of Nilotinib treatment on safety, tolerability, pharmacokinetics and biomarkers in Dementia with Lewy Bodies (DLB)
$1,792,741Charbel Moussa · Georgetown University · R01 · FY2021 · AG
DATA CENTER FOR THE ADOLESCENT MEDICINE HIV/AIDS NETWORK
$1,792,614University Of Alabama At Birmingham · U01 · FY2001 · HD
EHR-based Genomic Risk Assessment and Management for Diverse Populations
$1,792,493Chunhua Weng · Columbia University Health Sciences · U01 · FY2021 · HG
Molecular-Based Therapy for Oral Cancer Prevention
$1,792,413Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
Children's Oncology Group Chair's Grant
$1,792,218Peter C Adamson · National Childhood Cancer Foundation · U10 · FY2009 · CA
Nonmyeloablative allogeneic PBSC in globin disorders
$1,792,190John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Recanalization Therapies and Markers of Stroke Outcome
$1,792,178Joseph Paul Broderick · University Of Cincinnati · P50 · FY2010 · NS
Development of a Vaccine for HIVAIDS: Humoral Immunity
$1,792,105Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA